JAMA Dermatology

Article	Citations
Clinical and Pathological Spectrum of Prurigo Pigmentosa in Central European Individuals	912
Widespread Erythematous Plaques With Prominent Telangiectases	272
Treatment of Verruca Plana With Topical Combination of Calcipotriol and Fluorouracil	172
Error in Author Name	171
Error in Author Surname in Byline	145
Melanoma Screening	141
Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?	124
Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis Bullosa	114
Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark	110
Group Omitted From Article Byline	106
Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity	98
Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination	96
JAMA Dermatology	95
Tofacitinib for Treatment of Acquired Reactive Perforating Collagenosis	94
Recurrence Rate of Melanoma In Situ Excised With a 5-mm Excisional Margin	93
Cutaneous Angiosarcoma	87
Disordered Eating in Hidradenitis Suppurativa	79
Nicotinamide for Skin Cancer Chemoprevention	70
Current State of Dermatology Mobile Applications With Artificial Intelligence Features	68
Ultraprocessed Food Intake and Psoriasis	66
Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults	65
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database	65
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage	63
Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement	63
Parental E-Cigarette Use and Pediatric Atopic Dermatitis	63

Skin Cancer Care in US Veterans—Serving Those Who Served	56
Outcomes Associated With Combination Shaving and Cryosurgery Treatment in Patients With Keloid Scars	54
Alopecia Areata	53
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis	52
Prevalence of Contact Allergens in Natural Skin Care Products From US Commercial Retailers	51
Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa	50
Perceptions of US-Based Muslim Patients of Their Dermatology Care	50
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab	49
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice	48
Association of Treatment With Secukinumab With Exacerbation of Dermatomyositis in a Patient With Psoriasis	47
Treatment of Kimura Disease With Dupilumab	45
Novel Treatments for Chronic Erythema Multiforme Inform Translational Science and Disease Pathogenesis	45
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention	45
Treatment With Topical Sirolimus for Recurrent Lymphatic Malformation of the External Urethral Meatus	44
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults	44
Smoking Cessation and Risk of Hidradenitis Suppurativa Development	42
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records	42
Patient-Reported Outcomes in Dermatology	41
Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia	41
Assessment of Cutaneous Vasculitis and Quality of Life	41
ALK-Positive Histiocytosis—A Distinct Histiocytic Entity Deserving Recognition—Reply	40
COVID-19 as a Risk Factor For Autoimmune Skin Disease	40
Errors in Abstract, Results, and Table 1	39
Alectinib In the Treatment of Systemic Juvenile Xanthogranuloma of Infancy With ALK Translocation	39
JAMA Dermatology	39
Reexamining Medication Impact in Hidradenitis Suppurativa and Pregnancy—Reply	38
Rapid Improvement in Refractory Acute Generalized Exanthematous Pustulosis With Spesolimab	38
Treatment of Severe Dermatitis, Multiple Allergies, and Metabolic Wasting With Dupilumab	38
Validation of Case Identification for Melasma Using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision Codes	37
Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma	37
Serum Immunoglobulin G Levels and Nicastrin Variation in Hidradenitis Suppurativa	37
Methotrexate and Interstitial Lung Disease—Reply	36
Cooling Research Fever in Dermatology—The Role of Community Service—Reply	36
Considerations Regarding Mohs Surgery for Early-Stage Merkel Cell Carcinoma	35
The Quest for a More Accurate Diagnosis of Cellulitis	35
Trends in the Prevalence of Eczema Among US Children by Age, Sex, Race, and Ethnicity From 1997 to 2018	35
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa	34
Mohs Surgery vs Wide Local Excision in Primary High-Stage Cutaneous Squamous Cell Carcinoma	34
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones	34
Spesolimab Response in a Patient With Steroid-Resistant Sweet Syndrome	33
Antihypertensive Medications and Eczematous Dermatitis in Older Adults	33
Foscarnet-Induced Penile Ulceration	33
Error in Figure 4	33
Lesbian, Gay, Bisexual, and Transgender Identity and Disclosure Among Dermatologists in the US	33
Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics	32
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward	32
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases	32
A Firm Pigmented Plaque on the Forearm of a Child	32
Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis	32
Incidence of and Risk Factors for Keratinocyte Carcinoma After Pediatric Solid Organ Transplant	31

Numerous Angiomatous Lesions in an Infant	30
Association of Different Prescribing Patterns for Oral Corticosteroids With Fracture Preventive Care Among Older Adults in the UK and Ontario	30
Chloracne	30
High-Dose Upadacitinib Therapy for Refractory Metastatic Crohn Disease	30
JAMA Dermatology Peer Reviewers in 2022	30
Error in Figure 1	30
Errors in Figure 2 and Table 2 Footnotes	30
Oral Lichenoid Lesions Associated With Mediastinal Mass and Hypogammaglobulinemia in a Middle-aged Man	30
Error in Author Byline	29
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body	29
Research Fever in Dermatology—A Symptom of a Larger Problem	29
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea	29
Skin Cancer Risk Factors and Screening Among Asian American Individuals	29
Dermatologist Workforce Mobility	29
The Genomic and Phenotypic Landscape of Ichthyosis	28
Error in Table	28
A Tribute to Samuel Moschella	28
Incorporating Social Determinants of Health Into Medical Decision-making—Implications for Dermatology	28
A Case of Unilateral Focal Hyperkeratosis	28
Use of Patient-Reported Outcomes in Acne Vulgaris and Rosacea Clinical Trials From 2011 to 2021	28
Billing Patterns and Geographic Distribution of Dermatologist-Dermatopathologists in the US From 2013 to 2017	28
Legislative Efforts Restricting Care for Transgender People	28
Chemotherapy-Induced Pseudocellulitis Without Prior Radiation Exposure	27
JAMA Dermatology	27
Association of Sun-Protective Behaviors With Bone Mineral Density and Osteoporotic Bone Fractures in US Adults	27
Risk of New-Onset and Recurrent Depression and Anxiety Among Patients With Hidradenitis Suppurativa	27
Incidence and Prevalence of Morphea	27
Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex Severity	26
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis	26
Red Papulonodules in a Kidney Transplant Recipient	26
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus	26
Value-Driven Skin Cancer Surveillance for Transplant Recipients	26
CLOVES Syndrome	25
Successful Treatment of Stimulator of Interferon Genes–Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab	25
Differences in Face-to-Face Time Spent With a Dermatologist Among Patients With Psoriasis Based on Race and Ethnicity	25
Error in Table Footnote	25
Outcomes Associated With Neutropenia and Lymphopenia in Epidermal Necrolysis	25
Use of Reflectance Confocal Microscopy in Equivocal Lesions for the Diagnosis of Melanoma	25
Consent and Identifiability for Patient Images in Research, Education, and Image-Based Artificial Intelligence	24
Recurring Papules and Nodules on the Vulva	24
Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention	24
Skin-Related Quality of Life During Autoimmune Bullous Disease Course	24
Symptoms of Cognitive Impairment Among Children With Atopic Dermatitis	23
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy	23
Errors in the Affiliations and Corresponding Author Sections	23
Prevalence of Comorbidities Among Pediatric Patients With Hidradenitis Suppurativa	23
Recurrence Rate of Small Melanoma In Situ on Low-Risk Sites Excised With 5-mm Excisional Margin	23
Xeroradiography as a Noninvasive Tool in Diagnosing Calciphylaxis	22
Association of Biologic Treatment in Hidradenitis Suppurativa With Reduced Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio	22
CLAPO Syndrome	22
Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib	22
Mendelian Randomization for Dermatology Research	22
Cutaneous Herpetiform Ulcerations as the Presenting Sign of an Acute Aortic Occlusion	22
Potential Sexual Transmission of Tinea Pubogenitalis From TMVII	22
Palmar Fasciitis and Polyarthritis Syndrome	21
Evaluation of Thalidomide Treatment of Patients With Chronic Erythema Multiforme	21
Smooth, Firm, Skin-Colored Papules on the Nasal Dorsum	21
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease	21
Artificial Intelligence and Dermatology	20
Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris	20
Annular Erythematous Eruption in a Pediatric Patient	20
Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors	20
Projective Personification Approach to the Experience of People With Acne and Acne Scarring—Expressing the Unspoken	20
Evaluation of Gabapentin and Transforaminal Corticosteroid Injections for Brachioradial Pruritus	20
JAMA Dermatology Peer Reviewers in 2024	20
Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis	20
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa	19
Epitope Spreading in Immune Checkpoint Inhibitor–Associated Bullous Pemphigoid	19
Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank	19
Evaluation and Treatment of Febrile Ulceronecrotic Mucha-Habermann Disease With Ruxolitinib and Tocilizumab as Guided by Cytokine Profile	19
Lack of Transparency and Potential Bias in Artificial Intelligence Data Sets and Algorithms	19
JAMA Dermatology	19
Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis	18
Eruptive Xanthomas	18
HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US	18
The Importance of Hair in Black−White Race Relations	18
Fibromyalgia in Patients With Hidradenitis Suppurativa	18
Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata	18
Error in Text	18
Benign Familial Pemphigus in Skin of Color	18

Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants	17
Diversity and Career Goals of Graduating Allopathic Medical Students Pursuing Careers in Dermatology	17
A Reddish Semitransparent Tumor in an Adolescent Girl	16
Acrodermatitis Enteropathica	16
Radiation Recall Dermatitis With Bruton Tyrosine Kinase Inhibitor Therapy	16
JAMA Dermatology	16
Geographic Distribution and Workforce Diversity of Dermatology Physician Assistants—Reply	16
Sudden Conjunctivitis, Lymphopenia, and Rash Combined With Hemodynamic Changes (SCoRCH) After Trimethoprim-Sulfamethoxazole Use	16
Granulomatous Cheilitis in a Young Woman	16
Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn Disease	16
Eruptive Acral Nevi Secondary to Treatment With Chemotherapy	16
Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age	16
Content Analysis of Patient-Reported Outcome Measures Used in Patients With Nail Conditions	16
Improvement of Hailey-Hailey Disease With Topical Cinacalcet, 3%, Ointment	16
Nonmelanoma Skin Cancer in Patients Older Than Age 85 Years Presenting for Mohs Surgery	16
Granulomatosis With Polyangiitis Presenting With Strawberry Gums	15
Response of Severe Lupus Miliaris Disseminatus Faciei to Treatment With Ruxolitinib Cream	15
UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome	15
Diagnosis of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors	15
Adjuvant Immunotherapy in Stage II Melanoma—Further Risk Stratification is Needed	15
Rubella Virus–Associated Granulomas in Immunocompetent Adults—Possible Implications	15
Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab	15
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF)	15
Safety and Effectiveness of Oral Nutraceuticals for Treating Acne	15
Genetic Susceptibility to Hidradenitis Suppurativa and Predisposition to Cardiometabolic Disease	14
Treatment of Netherton Syndrome With Abrocitinib	14
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults	14
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis	14
Prevalence of Pretreatment Testing Recommended for Patients With Chronic Inflammatory Skin Diseases	14
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis	14
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis	14
Patient Perspectives on Living With Severe Prurigo Nodularis	14
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma	14
Pigmentary Changes in a Woman With Oral Lichen Planus	13
Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis	13
Olmsted Syndrome	13
Error in Box	13
Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis	13
Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma	13
JAMA Dermatology	13
Tuberculous Mastitis	13
Response of Widespread Generalized Essential Telangiectasia Following Treatment With Oral Dabigatran	13
Hypertrophic Tongue Papillae in Cowden Syndrome/PTEN Hamartoma Tumor Syndrome	13
Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment	13
Perspectives and Strategies to Minimize Harm From Melanoma Diagnosis	13
JAMA Dermatology	13
Generalized Micropapular Eruption in a Teenager	13
Incidence and Factors Associated With Second Primary Invasive Melanoma in Norway	13
Pyoderma Gangrenosum	13
Annular Cutaneous Lesion of the Neck	13
Sunburn and Cutaneous Squamous Cell Carcinoma	13
Perspectives on Use of the Cutaneous Direct Immunofluorescence Assay—Reply	12
Intralesional Certolizumab for Refractory Lupus Pernio	12
Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis	12
The Consideration of Cyclosporine in the Treatment of Stevens-Johnson Syndrome	12
Topical β-Blocker Wet Wrap Therapy for Amivantamab-Induced Scalp and Facial Necrosis	12
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children	12
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery	12
Treatment of Porokeratosis Ptychotropica With a Topical Combination of Cholesterol and Simvastatin	12
Genetic Variants Associated With Hidradenitis Suppurativa	12
Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms—Reply	12
Reanalysis of Study After Removal of Participants in 1 Trial of Upadacitinib for Atopic Dermatitis	12
Arc-Shaped Furrow on the Forehead Extending From Linear Alopecia on the Vertex	12
Unusual Congenital Scalp Lesion in a Child	12
Clinical Features and Outcomes of Black Patients With Melanoma	12
Chronic Mucocutaneous Candidiasis Due to STAT1 Gene Variant	12
Risk of Hematologic Cancer in Patients With Undifferentiated Pruritus	12
Gene-Environment Interaction Between CYP1B1 and Oral Contraception on Frontal Fibrosing Alopecia	12
Onychomycosis	12
Genital and Perigenital “W”-Shaped Telangiectasias in Women With Limited Cutaneous Systemic Sclerosis	12
Checklist for Evaluation of Image-Based Artificial Intelligence Reports in Dermatology	12
Facilitators and Barriers to the Timely Diagnosis and Treatment of Melanoma in Latino Persons	12
Treatment of Suspected Rubella Virus–Associated Granulomatous Dermatitis With Adalimumab	12
JAMA Dermatology’s Commitment to Diversity, Equity, and Inclusion	11
Improving Outcomes in Chronic Graft-vs-Host Disease	11
Interleukin-17 Inhibitors and Early Major Adverse Cardiovascular Events	11
Clinical Data on Laboratory Testing for Patients Taking Systemic Immunomodulatory Agents	11
Successful Treatment of Recalcitrant Mpox Lesions With Intralesional Cidofovir in a Patient With HIV/AIDS	11
Sarcoidosis of the Skin	11
Cutaneous Anthrax	11
Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum	11
Navigating Melanoma In Situ in the Age of Overdiagnosis	11
Association Between Low-Dose Methotrexate Exposure and Melanoma	11
Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230	11
JAMA Dermatology	11
Risk of All-Cause Mortality, Cardiovascular Disease Mortality, and Cancer Mortality in Patients With Bullous Pemphigoid	11
Risk of Alopecia Areata After COVID-19	11
Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease	11
Trichophyton mentagrophytes Internal Transcribed Spacer Genotype VIII	11
Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements	11
Human Polyomavirus 9—An Emerging Cutaneous and Pulmonary Pathogen in Solid Organ Transplant Recipients	10
Evaluation of Stigma Toward Individuals With Acne	10
Hunter Syndrome	10
Carbon Footprint Analysis of an Outpatient Dermatology Practice at an Academic Medical Center	10
Use of Dupilumab to Manage Antibody-Drug Conjugate–Induced Cutaneous Toxicities	10